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The  efﬁcacy  of  eprinomectin  in  an  extended-release  injection  (ERI)  formulation  was  deter-
mined in cattle  harboring  naturally  acquired  infestations  of ﬁrst-  or second-  and  third-stage
larvae of  Hypoderma  spp.  in  three  studies  conducted  according  to the  same  protocol  in  the
USA (two  studies)  and  Germany  (one  study).  Thirty  cattle  sourced  from  herds  with  a history
of Hypoderma  infestation  were  included  in  each  study.  Cattle  were  formed  into  replicates
of three  animals  each  on  the  basis  of  pre-treatment  anti-Hypoderma  antibody  titers.  Within
replicates  each  animal  was  randomly  allocated  to  one  of  the following  treatments:  ERI vehi-
cle (control)  at  1 mL/50  kg  bodyweight,  administered  once  on  Day  0; Eprinomectin  5% ERI
at 1 mL/50  kg  bodyweight  (1.0 mg  eprinomectin/kg),  administered  once  on  Day  0 (when
larvae  were  expected  to be ﬁrst instars);  or Eprinomectin  5% ERI  at 1  mL/50  kg bodyweight
(1.0  mg  eprinomectin/kg),  administered  once  when  larvae  were  second  or third  instars
(study  dependent,  Day  73, 119,  or 140).  Treatments  were  administered  by subcutaneous
injection  in  front  of  the shoulder.  In  all  studies,  emerging  and/or  expressed  Hypoderma  lar-
vae were  recovered,  speciated,  and  counted  and  viability  was  determined.  Eprinomectin  LAI
treatment was  100%  (p < 0.05)  efﬁcacious  against  ﬁrst-  and  second-  or third-stage  larvae  of
Hypoderma bovis  (two  studies)  and  Hypoderma  lineatum  (one  study).  All animals  accepted
the  treatment  well.  No  adverse  reaction  to treatments  was  observed  in  any  animal  in any
study.
 . Introduction
Warble ﬂies are relatively host-speciﬁc species of
yiasis-producing dipterans whose larvae dwell as sub-
utaneous parasites and may  produce boil-like swellings
warbles) under the skin of mammals. Hypoderma bovis
Linnaeus, 1758) and Hypoderma lineatum (De Villers,
789) (Diptera: Oestridae: Hypodermatinae) are com-
only referred to as ‘ox warbles’, warble ﬂies, cattle grubs
r  northern hemisphere grubs and are parasites of cattle,
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rarely affecting horses, sheep, or man. They occur through-
out  the Holarctic region (Zumpt, 1965).
The biology of H. bovis and H. lineatum is similar in many
respects. The adult ﬂies, which do not feed and live only for
a  short time, occur in late spring and summer, particularly
from May  to August/early September. H. lineatum tends
to  appear about one month before H. bovis. The female
ﬂies afﬁx their eggs directly to cattle hairs (mainly legs,
more rarely on lower parts of the body). The ﬁrst stage lar-
vae  hatch from the eggs within a week and penetrate the
Open access under CC BY-NC-ND license.host’s  skin. The larvae of H. bovis and H. lineatum reach the
skin  of the animal’s back after migration from the sites of
oviposition via the epidural fat in the spinal canal (H. bovis)
or  the submucosal connective tissue of the esophagus
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(H. lineatum) by burrowing between the sheets of connec-
tive tissue. Several months elapse before the larvae reach
their ﬁnal site in the region of the lumbar and posterior tho-
racic vertebrae. With the onset of the following spring, the
larvae arrive under the skin of the back, where swellings
begin to develop as a host reaction to the larvae. The infes-
tation is in the ‘warble’ stage, when the skin over each
swelling becomes perforated, allowing the larva to breathe.
Warbles of H. lineatum appear in the backs of animals from
January up to April/May, while those of H. bovis appear
between March and July. Within a period of one to two
months, the larva in the warble molts twice and grows
rapidly. The mature larva emerges through the warble pore
and falls to the ground to pupate for one to three months.
The entire life cycle is approximately one year in duration
and thus results in only a single generation per year.
Hypoderma spp. are important economic pests of cat-
tle, and losses arise from a number of causes. Although
the principal impact from these ﬂies is associated with the
parasitism of the larval stages, losses also are attributed
to the imagos. The disturbance of grazing cattle caused by
ovipositing ﬂies, especially H. bovis, may  result in an avoid-
ance behavior which is known as ‘gadding’. It has been
associated with interruption of grazing, altered reproduc-
tion patterns, self-injury, poor weight gain, and reduced
milk yield. The most signiﬁcant losses, however, are asso-
ciated with the Hypoderma larvae: warbles and damage to
other tissues during migration of the larvae may  require
excessive trimming of discolored ﬂesh in slaughtered cat-
tle, and the perforation of the skin by the larvae, as well
as the scars of healed warbles, cause condemnation or
greatly reduce the value of the hides (Kettle, 1984; Wall
and Shearer, 2001; Catts and Mullen, 2002; Colwell et al.,
2006).
The prevalence of Hypoderma spp. has decreased
markedly following the use of systemically acting macro-
cyclic lactones in national eradication programs which
have been undertaken in many countries. Nevertheless,
the prevalence of Hypoderma infestation in cattle can be
considerable in certain areas, and Hypoderma spp. have a
great capacity for population (re)generation if eradication
or control measures are incomplete or if re-introduction
(importation of infested cattle or ﬂy immigration) occurs
(O’Brien, 1998; Scholl, 1998; Colwell, 2002; Colebrook and
Wall, 2004).
Eprinomectin, a second-generation avermectin, is a
member of the macrocyclic lactone class of parasiticides.
Its endectocidal activity in a 0.5% formulation consist-
ing of natural oils for pour-on administration at 0.5 mg
eprinomectin/kg bodyweight has been documented in
numerous laboratory and ﬁeld studies world-wide (e.g.,
Shoop et al., 1996; Barth et al., 1997; Gogolewski et al.,
1997a,b; Holste et al., 1997, 1998; Pitt et al., 1997; Williams
et al., 1997; Yazwinski et al., 1997; Batty et al., 1999;
Epe et al., 1999; Cramer et al., 2000; Dorny et al., 2000;
Campbell et al., 2001; Davey and George, 2002; Rehbein
et al., 2005).In order to extend the persistency of activity of epri-
nomectin against endoparasites, an injectable formulation
has been developed which releases the active over time
in concentrations that provide effective prevention ofology 192 (2013) 353– 358
nematode infections in cattle for up to 150 days (Soll et al.,
2013). In this extended-release injection (ERI) formula-
tion, eprinomectin is released from a matrix formed with
poly(d,l-lactide-co-glycolic)acid (PLGA). PLGA is known as
a safe and effective biodegradable material which has been
used as a drug delivery system for extended-release appli-
cations of various pharmaceutical compounds including
ivermectin (Lewis, 1990; Miller et al., 1999; Clark et al.,
2004; Winzenburg et al., 2004).
The objective of the present studies was to conﬁrm
the efﬁcacy of Eprinomectin ERI against naturally acquired
infestations of ﬁrst or second and third larval stages of
Hypoderma spp. in cattle.
2. Materials and methods
A total of three controlled studies were conducted
according to the same protocol, two in the USA and one
in Germany. The studies were designed and conducted
to comply with the regulatory requirements of both the
FDA/CVM and the European Medicines Agency/Committee
for Medicinal Products for Veterinary Use, and according
to relevant guidelines for good clinical practices (GCPs)
and for establishing the efﬁcacy of ectoparasiticides against
myiasis-causing parasites (Holdsworth et al., 2006).
The studies were performed as blinded studies, i.e., all
personnel involved in collecting data were masked to the
treatment assignment of the animals.
2.1. Experimental animals
A total of 90 (1 male, 49 male castrate and 40 female)
healthy, ruminating Angus, Angus cross, Hereford, Here-
ford/Angus cross, Hereford/Red Angus cross, Hereford
cross, Red Angus, Rotbunte, Schwarzbunte, Shorthorn cross
or Simmental cross cattle were included in three studies,
conducted in the USA (Studies 1 and 3) or in Germany
(Study 2). The cattle were approximately 5–25 months
old and weighed 150–482 kg prior to treatment (Day −1
or Day 0). The animal descriptions and details are pre-
sented in Table 1. The animals were sourced from herds
with Hypoderma infestation history in Wyoming (Study
1) or Wisconsin (Study 3), USA and in the Rhine Palati-
nate, Germany (Study 2). Animals had not been treated
previously with an avermectin or milbemycin product and
had previous exposure to Hypoderma spp. as conﬁrmed
by the presence of anti-Hypoderma antibodies prior to
treatment.
Animals were handled with due regard for their welfare
and in compliance with Merial Institutional Animal Care
and Use Committee (IACUC) approvals, local regulations
and requirements of any local IACUC.
2.2. Experimental design
A randomized block design based on pre-treatment
anti-Hypoderma antibody levels was used with the indi-
vidual animal being the experimental unit in each study.
Ten replicates of three cattle each were formed sequen-
tially based on decreasing pre-treatment anti-Hypoderma
antibody test (Studies 1 and 3: ELISA test as described
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by Colwell et al. (1997);  Study 2: Hypodermosis ELISA,
Vétoquinol, Lure, France) results. Within replicates, ani-
mals were randomly allocated to treatment: one to the
control (vehicle-treated) group, one to the Eprinomectin
ERI group to be treated when the Hypoderma spp. larvae
were expected to be ﬁrst-stage larvae, and one to the Epri-
nomectin ERI group to be treated when the Hypoderma
spp. larvae were in the second/third stage, for a total of
10 animals per group each.
Cattle were held indoors and were individually stan-
chioned (Study 2) or were held in indoor/outdoor (Study
3) or outdoor (Study 1) pens by treatment group.
Animals were fed as per local practice and were pro-
vided water ad libitum. The studies were initiated
either in November (Study 1) or in December (Studies
2 and 3).
Both vehicle (formulation consisting of the excipients
of the Eprinomectin ERI) and Eprinomectin 5% (w/v) ERI
(eprinomectin in a PLGA-based formulation; dosed at
1.0 mg  eprinomectin/kg), were administered at 1 mL/50 kg
(1 mL/110 lb) bodyweight by subcutaneous injection in
front of the shoulder using commercial disposable syringes
and needles. Two groups of cattle were treated on a single
occasion with either ERI-vehicle or Eprinomectin ERI when
the Hypoderma spp. larvae were expected to be ﬁrst-stage
larvae and no warbles were visible (Day 0: all studies). A
third group was  treated with Eprinomectin ERI once when
warbles were visible and the Hypoderma spp. larvae were
in the second/third stage (Day 73: Study 1; Day 119: Study
2; Day 140: Study 3).
Animals were weighed prior to treatments (Days 0 and
73: Study 1; Days 0 and 119: Study 2; Days −1 and 140:
Study 3) for dose calculation.
All cattle were observed hourly for 4 h post-treatment
and thereafter once daily throughout the studies for health
problems or adverse drug events.
Cattle were inspected for warbles starting on study
Day 38 (Study 1) or Day 42 (Studies 2 and 3) at inter-
vals no greater than two weeks until warbles were
detected in a minimum of six cattle in the group to
be treated when the Hypoderma spp. larvae were in
the second/third stage. Thereafter, cattle were inspected,
and adequately mature Hypoderma spp. larvae were
collected, viability was  determined, and larvae were iden-
tiﬁed to species, when possible. Cattle were examined
until study termination, i.e., until larvae were no longer
emerging.
2.3. Statistical methods
The counts of live Hypoderma spp. larvae were
transformed to the natural logarithm of (count + 1) for cal-
culation of geometric means. Eprinomectin ERI treatment
groups were compared separately to the ERI vehicle-
treated (control) group using the Wilcoxon rank sum test.
A two-sided test was used at the signiﬁcance level of 0.05.
Efﬁcacy was  calculated as 100[(C − T)/C], where C is the geo-
metric mean for the vehicle-treated (control) group and
T is the geometric mean for the Eprinomectin ERI-treated
group.
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Table 2
Hypoderma larval counts and therapeutic efﬁcacy of Eprinomectin ERI against natural infestations of ﬁrst-stage and second or third-stage larvae of
Hypoderma spp.
Studya Treatmentb Live Hypoderma larval countsc Efﬁcacyd Probabilitye
Number of cattle infested GMf (range)
Hypoderma lineatum larvae
1
Control 8/10 4.9 (0–26) – –
EpERI L1g 0/10 0 100% <0.05
EpERI  L2/L3h 0/10 0 100% <0.05
Hypoderma bovis larvae
2
Control 10/10 12.3 (1–52) – –
EpERI L1 0/10 0 100% <0.01
EpERI  L2/L3 0/10 0 100% <0.01
3
Control 7/10 1.8 (0–9) – –
EpERI L1 0/10 0 100% <0.05
EpERI  L2/L3 0/9i 0 100% <0.05
a Source of animals: Study 1 – Wyoming, USA; Study 2 – Rhine Palatinate, Germany; Study 3 – Wisconsin, USA.
b Control = ERI vehicle-treated; EpERI = Eprinomectin ERI.
c Number of larvae collected after treatment of cattle with second/third stage Hypoderma larvae until study termination (Study 1: Day 108, Study 2: Day
189  and Study 3: Day 182).
d Efﬁcacy = 100 × (GM control − GM Eprinomectin ERI/GM control).
e Probability from the Wilcoxon rank sum test.
f Geometric mean live larval counts (based on transformation to the natural logarithm of [count + 1]).
g Treatment during the ﬁrst larval stage of development.
h Treatment during the second/third larval stages of development.
ment.i One animal died of a lung hemorrhage on Study Day 42, prior to treat
3. Results
All larvae collected in Study 1 were identiﬁed as H. lin-
eatum, while all larvae collected in Studies 2 and 3 were
identiﬁed as H. bovis. At the time of treatment of animals
with second/third stage Hypoderma larvae, the following
warble numbers were counted: Study 1, Day 73: 1–34
warbles in 9/10 animals treated, and 2–33 warbles on
8/10 control animals; Study 2, Day 119: 2–37 warbles in
9/10 animals treated, and 4–32 warbles on 10/10 control
animals; Study 3, Day 140: 1–12 warbles in 6/9 animals
treated, and 1–9 warbles on 6/10 control animals.
Following treatment of groups apparently infected with
second/third-stage Hypoderma larvae, the number of war-
bles regressed to zero, within two (Studies 1 and 3) or six
weeks (Study 2). Hypoderma spp. larvae did not emerge
from any of the cattle treated when the larvae were either
expected to be ﬁrst-stage larvae or when the Hypoderma
spp. larvae were in the second/third stage. Each study was
continued until larvae were no longer emerging from the
vehicle-treated (control) animals (Study Days 108, 189, or
182 in Studies 1, 2, and 3, respectively.). By the conclusion
of each study, 97 live H. lineatum larvae and 175 and 30
live H. bovis larvae were collected from the vehicle-treated
(control) animals in Studies 1, 2 and 3, respectively. No live
Hypoderma larvae were collected from any treated animal
(Table 2).
Cattle treated with Eprinomectin ERI when Hypoderma
spp. were expected to be at the ﬁrst or second/third stages
had signiﬁcantly (p < 0.05) fewer H. lineatum or H. bovis lar-
vae emerging and/or expressed than the vehicle-treated
(control) animals. The efﬁcacy of Eprinomectin ERI against
the larval stages of H. lineatum or H. bovis was  100%
(Table 2).All animals were reported as normal during hourly
observations for 4 h post-treatment, indicating that the
treatment (either Eprinomectin ERI or ERI vehicle) was well
accepted. There were no drug related health problems or
adverse drug events observed at any time during the stud-
ies.
4. Discussion
The results presented herein clearly demonstrate that
eprinomectin in a ERI formulation is 100% efﬁcacious in the
treatment of cattle naturally infested with H. bovis and H.
lineatum larvae at all stages of development. Eprinomectin
ERI can, therefore, be used as “prophylactic” treatment for
Hypoderma spp. infestations, i.e., when there is no external
evidence of their presence and before damage to ﬂesh and
skin occurs, and as “therapeutic” treatment, e.g., when war-
bles are already present. Similar results were reported by
Holste et al. (1997) who  used a 0.5% eprinomectin pour-on
treatment at 0.5 mg  eprinomectin/kg bodyweight in cattle.
Serodiagnosis of hypodermosis was used to select study
animals as it is the only way  to detect infested animals
well before the appearance of the warbles on the ani-
mals; however, there is no correlation between titer level
and intensity of infestation (Sinclair et al., 1984; Boulard,
1985; Colwell and Baron, 1990). Although exclusively anti-
Hypoderma antibody positive animals were enrolled in the
current studies, detectable warbles ultimately developed
in only 81.4% of the controls and the groups of animals
scheduled for late-treatment, where larvae were allowed
to develop to the second/third stage prior to treatment. This
ﬁnding is consistent with the established predictive value
of available ELISA’s (Colwell and Baron, 1990; Pruett and
Kunz, 1996; Colwell, 2001; Colwell and Jacobsen, 2002),
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ut it may  also reﬂect to a certain degree the high larval
ortality in Hypoderma spp. infestations as they develop.
In studies using the intraruminal ivermectin sustained-
elease bolus designed to deliver ivermectin for approx-
mately 130 days, protection from Hypoderma spp. infes-
ation has been demonstrated in cattle for the whole iver-
ectin release period during the season of warble ﬂy activ-
ty (Freedom of Information Summary, IVOMEC®1 SR Bolus
or Cattle; http://www.fda.gov/cvm/FOI/140-988.pdf).
In conclusion, based on the efﬁcacy proﬁle of Epri-
omectin ERI which provides effective control of nematode
nfections in cattle for up to 150 days (Rehbein et al., 2013;
oll et al., 2013) and the exquisite sensitivity of Hypo-
erma spp. to the avermectins in general (Boulard, 1999;
ercruysse and Rew, 2002), it can be assumed that Epri-
omectin ERI treatment during the period when the adult
ies are ovipositing on cattle will also provide protection
o cattle from Hypoderma spp. larval infestation.
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